Assessment of neuroprotective peptides poly-arginine R18, COG1410, and APP96-110 experimental traumatic brain injury and in vitro neuronal excitotoxicity. Chiu LS, Anderton RS, Clark VW, Edwards AB, Knuckey NW, Meloni BP. (2017). Translational Neuroscience. DOI: https://doi.org/10.1515/tnsci-2017-0021

‘Investigation of poly-arginine peptide neuroprotective mechanisms using an in vitro neurotrauma injury model’. Meloni B, Knuckey N, Chiu L, Anderton R. $100,000. Neurotrauma Research Program.

The neuroprotective potential of arginine-rich peptides for the acute treatment of traumatic brain injury, Li Shan Chiu, Ryan S. Anderton, Neville W. Knuckey, Bruno P. Meloni, Expert Review of Neurotherapeutics, Volume 16, Issue 4, 2016, pages 361-363.

A/Prof Bruno Meloni, Clp Neville Knuckey, Ms Li Chiu, Dr Jane Cross, Mr Vince Clark 2015-16, ‘Pre-clinical assessment of arginine-rich peptides as a treatment to reduce brain damage following traumatic brain injury’, Brain Foundation.

Peptide pharmacological approaches to treating traumatic brain injury: a case for arginine-rich peptides. Li Shan Chiu, Ryan S. Anderton, Neville W. Knuckey, Bruno P. Meloni. Molecular Neurobiology. DOI: 10.1007/s12035-016-0287-3.